See every side of every news story
Published loading...Updated

HIV Drug Manufacturing Company Owes Big Money in Kickback Settlement Case

PENNSYLVANIA, JUL 16 – The $202 million settlement addresses illegal incentives that led to false claims in Medicaid and other federal programs from 2011 to 2017, with Pennsylvania receiving $1.28 million.

  • This past week, Pennsylvania Attorney General Dave Sunday announced Pennsylvania will receive $1.28 million as part of a $202 million settlement with Gilead Sciences, Inc.
  • From January 2011 to November 2017, Gilead Sciences, Inc. provided unlawful incentives including gifts, meals, and travel expenses, resulting in millions of dollars in false claims to government health programs.
  • Investigators found more than 250 prescribers attended identical programs three or more times in six months, and providers received tens to hundreds of thousands of dollars plus trips to Hawaii, Miami, and New Orleans.
  • These funds will support people living with HIV and bolstering prevention programs.
  • The settlement provides $49 million for Medicaid programs nationwide, the remainder goes to Medicare, Tricare, and ADAP, and Rob Bonta said the Trump tax bill is expected to slash Medicaid funding by $1 trillion over a decade.
Insights by Ground AI
Does this summary seem wrong?

11 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WTAJ News broke the news in on Tuesday, July 15, 2025.
Sources are mostly out of (0)

Similar News Topics